Fredric N. Eshelman, Director, 10% Owner at Furiex Pharmaceuticals, Inc. (FURX), bought 168,752 shares at $19.87 ($3.4M) on 2012-05-30, disclosed to the SEC on 2012-05-31.
Open-market purchase of $3.4M FURX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.96 | 72,431 | $1.4M | 43.0% |
| 2 | $19.87 | 96,321 | $1.9M | 57.0% |
| Total | $19.91 avg | 168,752 | $3.4M | 100% |
| Filing → |
| LQDA | SELL | 2021-01-21 | $872K | — | Filing → |
| LQDA | SELL | 2021-01-19 | $81K | — | Filing → |
| LQDA | SELL | 2021-01-15 | $219K | — | Filing → |